Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disorder of the Respiratory Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04540120
What this trial is testing

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Who this might be right for
Covid19Cytokine Release Syndrome
Olatec Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Large-scale testing (Phase 3)WithdrawnNCT02134106
What this trial is testing

Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria

Who this might be right for
BacteremiaHealthcare-associated PneumoniaVentilator-associated Pneumonia
Tan Tock Seng Hospital
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Large-scale testing (Phase 3)Study completedNCT04941105
What this trial is testing

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19

Who this might be right for
Sars-CoV-2 Infection
Collegium Medicum w Bydgoszczy 60
Large-scale testing (Phase 3)Study completedNCT01970371
What this trial is testing

Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

Who this might be right for
Bloodstream Infections (BSI) Due to CREHospital-Acquired Bacterial Pneumonia (HABP) Due to CREVentilator-Associated Bacterial Pneumonia (VABP) Due to CRE+2 more
Achaogen, Inc. 69
Not applicableStudy completedNCT04029675
What this trial is testing

High Dose of Vitamin C on Mechanically Ventilated Septic Patients in Intensive Care Unit

Who this might be right for
Ventilator Associated Pneumonia ( VAP)Sepsis
Ain Shams University 40
Not applicableUnknownNCT04648618
What this trial is testing

Obstructive Sleep Apnea and Diabetic Macular Edema Inflammatory Mediators

Who this might be right for
Diabetic Macular EdemaObstructive Sleep ApneaDiabetic Retinopathy
Uptown Eye Specialists 30
Large-scale testing (Phase 3)Study completedNCT04362813
What this trial is testing

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Who this might be right for
Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
Novartis Pharmaceuticals 454
Not applicableStudy completedNCT06653374
What this trial is testing

Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns

Who this might be right for
Preterm BirthLow Birth WeightIntrauterine Growth Restriction (IUGR)+11 more
HOSPITAL GINECO OBSTETRICO ISIDRO AYORA 26,000
Not applicableStudy completedNCT01676610
What this trial is testing

Infant Pulse Oximetry in Pakistan Study

Who this might be right for
HypoxemiaNeonatal SepsisPneumonia
The Hospital for Sick Children 3,149
Post-approval studies (Phase 4)Study completedNCT02479074
What this trial is testing

The Utility of feNO in the Differential Diagnosis of Chronic Cough

Who this might be right for
Cough
Hull University Teaching Hospitals NHS Trust 49
Not applicableActive Not RecruitingNCT03960359
What this trial is testing

Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years)

Who this might be right for
Asthma
University Hospital, Lille 150
Early research (Phase 1)Study completedNCT02084485
What this trial is testing

PH-797804 LPS Study in Healthy Volunteers

Who this might be right for
Healthy
Pfizer 24
Testing effectiveness (Phase 2)Study completedNCT04920916
What this trial is testing

Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
University of Virginia 40
Not applicableWithdrawnNCT07018804
What this trial is testing

Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Not applicableLooking for participantsNCT07123909
What this trial is testing

Studies on Adsorption International Learning Initiative Global

Who this might be right for
CKD (Chronic Kidney Disease) Stage 5DUremia; ChronicUremic; Toxemia+5 more
Botkin Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03989635
What this trial is testing

Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.

Who this might be right for
AsthmaAsthma, BronchialBronchial Asthma+2 more
Novartis Pharmaceuticals
Not applicableStudy completedNCT00880204
What this trial is testing

Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training

Who this might be right for
SepsisAsthmaHeart Failure+2 more
Child Advocacy International 36
Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing

Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28
Next Page